ArriVent BioPharma (AVBP) Times Interest Earned (2023 - 2026)
ArriVent BioPharma (AVBP) posted Times Interest Earned of -$1.15 for Q1 2026, up 99.5% sequentially from -$231.09 in Q4 2025, and up 49.09% YoY from -$0.77 in Q1 2025.
ArriVent BioPharma (AVBP) Times Interest Earned (2023 - 2026) Analysis & Trends
ArriVent BioPharma has reported Times Interest Earned for 4 years, with the latest figure at -$1.15 in Q1 2026.
- Quarterly Times Interest Earned rose 49.09% year-over-year to -$1.15 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.92 (up 17.64% YoY) and the FY2025 annual result came in at -$5.6, down 199.25% from the prior year.
- Times Interest Earned grew to -$1.15 in Q1 2026 per AVBP's latest filing, from -$231.09 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$0.52 in Q4 2023 and troughed at -$231.09 in Q4 2025.
- A 4-year average of -$28.15 and a median of -$1.03 in 2026 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2024 and 2026: Times Interest Earned plunged 7964.59% in 2024, then surged 49.09% in 2026.
- Over 4 years, Times Interest Earned stood at -$0.52 in 2023, then slumped by 7964.59% to -$42.25 in 2024, then sank by 446.89% to -$231.09 in 2025, then soared by 99.5% to -$1.15 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$1.15, -$231.09, and -$1.35 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | ArriVent BioPharma | 1.43 Bn | 1.43 Bn | - | -0.46 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.46 |
| Mar 31, 2026 | -1.15 |
| Dec 31, 2025 | -231.09 |
| Sep 30, 2025 | -1.35 |
| Jun 30, 2025 | -0.91 |
| Mar 31, 2025 | -2.26 |
| Dec 31, 2024 | -42.25 |
| Sep 30, 2024 | -0.57 |
| Jun 30, 2024 | -0.78 |
| Mar 31, 2024 | -0.63 |
| Dec 31, 2023 | -0.52 |